SCHEMBL4420719

SCHEMBL4420719

CCCCCCCCCCC(=O)N(CCNC(=O)OC(C)(C)C)c1ccncc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 1/20 0.44
NAAA Q02083 1/20 0.41
MTNR1A P48039 1/20 0.40
MTNR1B P49286 1/20 0.40
NPC1 O15118 2/20 0.39
RAB9A P51151 2/20 0.39
JAK2 O60674 1/20 0.39
PAX8 Q06710 1/20 0.39
LTB4R2 Q9NPC1 1/20 0.39
LATS1 O95835 2/20 0.39
DRD2 P14416 3/20 0.39
TDP1 Q9NUW8 1/20 0.39
MAPT P10636 2/20 0.38
KDM4E B2RXH2 1/20 0.38
CSNK2A2 P19784 1/20 0.37
CSNK2A1 P68400 1/20 0.37
CKS1B P61024 1/20 0.37
SKP1 P63208 1/20 0.37
SKP2 Q13309 1/20 0.37
MEN1 O00255 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7143106 0.80 LTB4R2 (0.48) NAAANPC1RAB9AJAK2PAX8
SCHEMBL17532682 0.76 TDP1 (0.46) TDP1CKS1BSKP1SKP2MEN1
SCHEMBL6955341 0.75 MAOA (0.46) CYP3A4NPC1RAB9ALATS1TDP1
SCHEMBL6953013 0.75 MAOA (0.46) CYP3A4NPC1RAB9ALATS1TDP1
SCHEMBL18865529 0.74 TDP1 (0.55) CYP3A4DRD2TDP1MEN1LMNA
SCHEMBL18865536 0.74 TDP1 (0.55) CYP3A4DRD2TDP1MEN1LMNA
SCHEMBL18865427 0.74 TDP1 (0.55) CYP3A4DRD2TDP1MEN1LMNA
SCHEMBL24288428 0.73 TDP1 (0.54) DRD2TDP1MEN1LMNATSHR
SCHEMBL25196839 0.73 TDP1 (0.54) CYP3A4TDP1MEN1LMNATSHR
SCHEMBL15283620 0.72 CKS1B (0.50) CYP3A4MTNR1AMTNR1BDRD2TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1691845-A4 COMPOUNDS CONTAINING MATRIX METALLOPROTEINASE SUBSTRATES AND METHODS OF THEIR USE BRISTOL MYERS SQUIBB PHARMA CO (US) 2009-02-25 EP disclosed
EP-1691845-A1 COMPOUNDS CONTAINING MATRIX METALLOPROTEINASE SUBSTRATES AND METHODS OF THEIR USE Bristol-Myers Squibb Pharma Company (US) 2006-08-23 EP disclosed
WO-2005023314-A1 COMPOUNDS CONTAINING MATRIX METALLOPROTEINASE SUBSTRATES AND METHODS OF THEIR USE BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) 2005-03-17 WO disclosed